CIP
PBH icon

Champlain Investment Partners’s Prestige Consumer Healthcare PBH Stock Holding History

Champlain Investment Partners’s Portfolio PBH Stock Details PBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-849,435
Closed -$51.5M – 148
2021
Q4 		$51.5M Sell
849,435
-234,775
-22% -$13.9M 0.23% 119
2021
Q3 		$60.8M Sell
1,084,210
-1,018,415
-48% -$55.9M 0.29% 117
2021
Q2 		$110M Buy
2,102,625
+5,205
+0.2% +$250K 0.52% 87
2021
Q1 		$92.5M Sell
2,097,420
-402,990
-16% -$16.9M 0.48% 91
2020
Q4 		$87.2M Buy
2,500,410
+72,930
+3% +$2.59M 0.5% 82
2020
Q3 		$88.4M Buy
2,427,480
+19,135
+0.8% +$712K 0.6% 65
2020
Q2 		$90.5M Sell
2,408,345
-53,975
-2% -$2.16M 0.65% 62
2020
Q1 		$90.3M Buy
2,462,320
+86,915
+4% +$3.38M 0.81% 50
2019
Q4 		$96.2M Buy
2,375,405
+220,480
+10% +$8.22M 0.7% 62
2019
Q3 		$74.8M Buy
2,154,925
+43,520
+2% +$1.43M 0.62% 74
2019
Q2 		$66.9M Buy
2,111,405
+22,465
+1% +$668K 0.56% 79
2019
Q1 		$62.5M Buy
2,088,940
+44,975
+2% +$1.29M 0.54% 82
2018
Q4 		$63.1M Sell
2,043,965
-34,580
-2% -$1.26M 0.64% 69
2018
Q3 		$78.8M Buy
2,078,545
+190,125
+10% +$7.19M 0.7% 66
2018
Q2 		$72.5M Buy
1,888,420
+114,365
+6% +$3.86M 0.7% 66
2018
Q1 		$59.8M Buy
1,774,055
+647,440
+57% +$24.8M 0.65% 68
2017
Q4 		$50M Buy
1,126,615
+493,365
+78% +$22.5M 0.57% 80
2017
Q3 		$31.7M Buy
633,250
+234,336
+59% +$12M 0.37% 96
2017
Q2 		$21.1M Buy
+398,914
New +$21.4M 0.26% 106
2015
Q1 		– Sell
-739,375
Closed -$25.7M – 138
2014
Q4 		$25.7M Sell
739,375
-159,400
-18% -$5.29M 0.41% 98
2014
Q3 		$29.1M Sell
898,775
-20,530
-2% -$687K 0.5% 91
2014
Q2 		$31.2M Buy
919,305
+9,320
+1% +$299K 0.51% 92
2014
Q1 		$24.8M Buy
909,985
+439,275
+93% +$13.1M 0.43% 101
2013
Q4 		$16.9M Buy
+470,710
New +$15.6M 0.3% 114

Other funds holding PBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Champlain Investment Partners's PBH Position: Q1 2022 in Review

Champlain Investment Partners sold out of Prestige Consumer Healthcare (PBH) in Q1 2022, closing a stake of 849,435 shares — an estimated $51.5M sold.

Champlain Investment Partners first reported a position in PBH in Q4 2013 and held it in 24 quarters. The position peaked at $110M in Q2 2021. 287 funds tracked by Wall St. Rank hold PBH as of Q1 2022.

  • Champlain Investment Partners reported no remaining Prestige Consumer Healthcare position as of Q1 2022 after selling out during the quarter.
  • Champlain Investment Partners sold 849,435 Prestige Consumer Healthcare shares in Q1 2022, an estimated $51.5M.
  • Champlain Investment Partners first reported a position in Prestige Consumer Healthcare in Q4 2013 and held it in 24 quarters.
  • Champlain Investment Partners's Prestige Consumer Healthcare position peaked at $110M in Q2 2021.
  • 287 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q1 2022.

Based on Champlain Investment Partners's 13F filing for Q1 2022, filed 12 May 2022.